(19)
(11) EP 4 771 017 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24858673.7

(22) Date of filing: 29.08.2024
(51) International Patent Classification (IPC): 
C07D 498/22(2006.01)
A61K 31/553(2006.01)
C07D 519/00(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/553; C07D 519/00; C07D 498/22; A61P 35/00
(86) International application number:
PCT/CN2024/115467
(87) International publication number:
WO 2025/045141 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 WO PCT/CN2023/116237
17.01.2024 WO PCT/CN2024/072724

(71) Applicant: Suzhou Zanrong Pharma Limited
Suzhou, Jiangsu 215123 (CN)

(72) Inventors:
  • WANG, Zheng
    Shanghai 200135 (CN)
  • ZHOU, Ding
    Shanghai 200230 (CN)
  • CHENG, Ziqiang
    Shanghai 201203 (CN)

(74) Representative: Simmons & Simmons LLP (Munich) 
Lehel Carré Gewürzmühlstraße 11
80538 Munich
80538 Munich (DE)

   


(54) KRAS INHIBITORS AND USES THEREOF